Differential mouse pulmonary dose and time course responses to titanium dioxide nanospheres and nanobelts
Public Domain
-
2013/01/01
-
Details
-
Personal Author:Andrew M ; Battelli L ; Castranova, Vincent ; Friend S ; Funk K ; Hamilton R ; Holian A ; Hubbs A ; Li J ; Meng F ; Mercer R ; Porter DW ; Sriram K ; Wolfarth M ; Wu N ; Yang F
-
Description:Three anatase titanium dioxide (TiO(2)) nanoparticles were prepared; nanospheres (NS), short nanobelts (NB1) and long nanobelts (NB2). These nanoparticles were used to investigate the effect of nanoparticle shape and length on lung toxicity. Mice were exposed (0-30 microg per mouse) by pharyngeal aspiration and pulmonary toxicity was assessed over a 112 day time course. Whole lung lavage data indicated that NB1- and NB2-exposed mice, but not NS-exposed mice, had significant dose- and time-dependent pulmonary inflammation and damage. Histopathological analyses at 112 days post-exposure determined no interstitial fibrosis in any NS-exposed mice, an increased incidence in 30 microg NB1-exposed mice, and significant interstitial fibrosis in 30 microg NB2-exposed mice. At 112 days post-exposure, lung burden of NS was decreased by 96.4% and NB2 by 80.5% from initial deposition levels. At 112 days post-exposure, enhanced dark field microscopy determined that alveolar macrophages were the dominant deposition site, but a fraction of NB1 and NB2 was observed in the alveolar interstitial spaces. For the 30 microg exposure groups at 112 days post-exposure, confocal microscopy and immunofluorescent staining demonstrated that retained NB2 but not NS were present in the interstitium subjacent to the terminal bronchiole near the normal location of the smallest lymphatic capillaries in the lung. These lymphatic capillaries play a critical role in particle clearance, and the accumulation of NB2, but not NS, suggests possible impaired lymphatic clearance by the high aspect ratio particles. In summary, our data indicate that TiO(2) nanoparticle shape alters pulmonary responses, with severity of responses being ranked as NSSubjects:Keywords:ISSN:1096-6080Document Type:Genre:Place as Subject:CIO:Division:Topic:Location:Pages in Document:179-193Volume:131Issue:1NIOSHTIC Number:nn:20041523Citation:Toxicol Sci 2013 Jan; 131(1):179-193Contact Point Address:Dale W. Porter, Ph.D., Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1095 Willowdale Road, M/S 2015, Morgantown, WV, 26505, USAEmail:DPorter@cdc.govCAS Registry Number:Federal Fiscal Year:2013NORA Priority Area:Peer Reviewed:TrueSource Full Name:Toxicological SciencesCollection(s):Main Document Checksum:urn:sha-512:9853b40ba20c5b43a7beec3e9d71dd8e254e4e6dda5436025eae68ced72944a0c2b4bf53475b8428f1145c8cf7d95127eee5f65b944ed648d7a5ff0df07a2e72Download URL:File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like